Position in ONC
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,473,579
-$1,344,072 QoQ
Shares Held
5,171
-45.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KBC Group NV holds $308,329,109 across 107 Biotechnology names. ONC ranks #17 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
179,508 | $111,930,417 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
128,466 | $63,812,914 | |
| 3 | INCY |
Incyte Corp
|
270,882 | $30,707,183 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
98,265 | $23,678,916 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
91,584 | $7,963,228 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,787,043 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
127,194 | $7,278,040 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $6,372,835 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,473,579 | 5,171 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $2,817,651 | 9,488 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $2,730,036 | 8,986 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $3,061,530 | 8,986 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $2,175,241 | 8,986 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,432,383 | 8,937 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $1,650,753 | 8,937 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $2,006,445 | 8,937 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $1,275,041 | 8,937 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $1,397,657 | 8,937 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $1,611,877 | 8,937 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,607,498 | 8,937 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $2,023,526 | 11,349 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $2,446,049 | 11,349 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $2,496,099 | 11,349 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $1,809,554 | 13,422 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $2,350,547 | 14,523 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $2,676,611 | 14,192 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $3,811,172 | 14,067 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $1,940,961 | 5,347 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,839,498 | 5,360 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $1,951,336 | 5,606 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $1,745,166 | 6,754 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $1,269,788 | 4,433 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $782,048 | 4,151 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $750,232 | 6,094 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||